SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD

Review checklist: Mary McLeod Bethune (HR-ML043)
All records · Back to the record · Dossier (sources.md) · Terminology · Report a problem · Comments
Everything a reviewer needs to judge, gathered from the record. Release status: draft.
- 20judgment calls in the dossier
- 1protocol deviations
- 2orders and referrals without results in the record
- 1evidence items to check (retrospective or sensitive claims, unconfirmed diagnoses)
Review status
| Review | Status | Reviewer | Date | Notes |
|---|
| schema validation | not_started | | | Run scripts/build.ps1 -Conformance. |
| clinical review | not_started | | | Awaiting clinician review; check the separation of asthma from COPD and heart failure (bronchodilator response, post-bronchodilator ratio, DLCO, FeNO, BNP and echocardiogram), the choice of GINA track 1 maintenance-and-reliever therapy and the decision not to step up before technique was corrected, the exacerbation management and the missed in-person review within a week, the biologic assessment, amlodipine rather than a beta-blocker, and the statin decision. |
| provenance review | not_started | | | She died in 1955; the recent-death rule does not apply. Claims rest on three National Park Service pages, two reference biographies on Encyclopedia.com, and the University Publications of America guide to her foundation's papers. Her chronic asthma and the 1942 attack are D from one reference biography, corroborated by the archival guide. The sinus surgery at Johns Hopkins could not be verified and is left out. Her heart disease before her fatal heart attack is not documented; the retrospective claim is R, possible. |
| safe messaging review | not_started | | | No mental health or substance claim is made; mood screens are synthetic and below the threshold for a safety assessment. Obesity is recorded in her words and with her agreement. Her death is recorded once, without detail. No relative is given a role in the modern episode; the president and the first lady of her Washington years are not named. |
Judgment calls (dossier editorial resolutions)
- Recent-death rule. She died in 1955, so the rule does not apply. The claims are still limited to what the fetched sources state.
- Sources not read. The New York Times obituary, the Library of Congress, the Florida Memory archive, Bethune-Cookman University and the National Council of Negro Women pages were not fetched successfully or not reached, and no peer-reviewed account of her health was found; none is cited.
- Asthma (D, one reference work). Her chronic asthma, its restriction of her travel and the severe attack of 1942 come from Women in World History (CLM-0005); the University Publications of America guide to her foundation’s papers independently lists “Bethune asthma attacks” in her 1943 correspondence (CLM-0006). Both are graded D with certainty “probable” because neither gives clinical detail. The age at onset, the treatment she received and any testing are not recorded and are not claimed.
- Sinus surgery not used. The assignment mentioned sinus surgery at Johns Hopkins in the 1930s. No fetched source mentions it (searches found only unrelated material about the Canadian surgeon Norman Bethune), so it is left out of the claims and of the modern episode. The modern chronic rhinosinusitis is synthetic; the record gives her no past sinus operation so that nothing reads as a claim about the unverified surgery.
- Heart disease (R). The sources say only that she died of a heart attack. No heart symptoms, blood pressure readings or cardiac diagnosis during her life were found. CLM-0011 records, as R with certainty “possible,” that a fatal heart attack at 79 is most consistent with coronary heart disease. The modern hypertensive heart disease without heart failure (I11.9) is synthetic, chosen so that the teaching can exclude heart failure as the cause of her breathlessness while still finding and treating heart disease; it is not linked to the death claim.
- Date of death. Two reference biographies give May 18, 1955, in Daytona Beach; one National Park Service page gives May 20 and says she died at home. May 18 is preferred; May 20 is recorded as a conflicting alternative.
- Merger date. The National Park Service dates the merger with Cookman Institute to 1923; Contemporary Black Biography says the school was renamed Bethune-Cookman College in 1929. Both are recorded in CLM-0003.
- Index age and dates. The synthetic date of birth is July 10, 1953 (shift 78 years). The index visit on March 9, 2026 maps to March 9, 1948, when she was 72: six years after the documented severe attack of 1942 and before she left public life in 1950. All visits map to March to September 1948, within her lifetime. Index age 72 is within the requested range of 70 to 74; she turns 73 before the fourth visit. The visits are not a claim about her real care or whereabouts in 1948; the modern episode places her home in Daytona Beach with monthly travel to Washington, as her documented life did.
- Intake claims. Claims about events after March 1948 (her retirement in 1950, the 1950 and 1952 entries in her papers, her death) are linked only to later timeline events and do not appear in the intake documents.
- Presenting problems. Wheeze, cough and breathlessness (R06.2) are resolved at the diagnosis visit on March 23, 2026, when asthma (J45.40, both_with_link to the documented asthma), hypertensive heart disease without heart failure (I11.9) and hyperlipidemia (E78.5) are recorded. Nasal congestion (R09.81) is resolved on May 4, 2026, when chronic rhinosinusitis without nasal polyps (J32.9) is recorded after nasal endoscopy. Reflux (K21.9) and obesity, class 1 (E66.811) are recorded at intake. The intake documents state only what was known then.
- Diagnostic choices. Asthma is separated from COPD by a 270 mL (21 percent) bronchodilator response, a post-bronchodilator FEV1/FVC of 0.72 and a normal DLCO in a never smoker; heart failure is excluded by a BNP of 48 pg/mL, a normal ejection fraction, a normal left atrium and no edema. The ICD-10-CM code J45.40 (moderate persistent) is used for billing; GINA does not grade severity before treatment, and her severity is judged by the treatment that controls her (low to medium dose ICS-formoterol), so she does not have severe asthma.
- Treatment choices. GINA track 1 budesonide-formoterol maintenance and reliever from the diagnosis, replacing albuterol alone; at six weeks the inhaler technique and adherence were corrected rather than the dose stepped up; during the exacerbation the maintenance dose was increased to two inhalations twice daily with five days of prednisone, and stepped back down once control was regained. Amlodipine was chosen for hypertension because beta-blockers can worsen asthma and an ACE inhibitor's cough would confuse the asthma review. A moderate-intensity statin was started for an estimated 10-year ASCVD risk above 20 percent. Biologic therapy was assessed and found not indicated. These are clinical judgment calls for review.
- Obesity. Recorded in her words and with her agreement; the record states plainly that her breathlessness is from asthma and not her weight, offers a dietitian and a walking plan as she chooses, and leaves a discussion of weight medicines to her.
- Equity. The record reads her spirometry with race-neutral GLI Global equations (ATS 2023) and says why that matters, and cites the documented higher asthma death rates among Black Americans (MMWR 2021). The history of clinicians dismissing her breathlessness as weight or age is synthetic and not a claim about her real care.
- Synthetic clinical picture. All visits, results, imaging, lung function, FeNO, IgE and allergen results, the echocardiogram, her height (163 cm) and weights, and every medicine are synthetic. Qualitative results (specific IgE, nasal endoscopy, ECG, chest X-ray) are in procedure and note text.
- Sick visit. A moderate asthma exacerbation with a cold (J45.41), chosen because it is the commonest and most instructive event in asthma care: it tests the action plan, the distinction from heart failure and the short oral corticosteroid course, and insinuates no undocumented real diagnosis. It is not a claim about any documented attack.
- Annual wellness visit. A subsequent annual wellness visit at 73 (HCPCS G0439 and CPT 99497 in plain text): influenza, COVID-19 and RSV vaccines; PCV20 already given in March; zoster and Tdap up to date from synthetic history; DXA ordered (65 or older with a recent prednisone course); mammography ordered; and advance care planning with an unnamed surrogate.
- Focused visits. The three chronic-care follow-ups (diagnosis and consultation, six weeks, and six weeks after the exacerbation) are documented as focused visits on GINA 2025, the 2020 NAEPP focused update, the CMID asthma and hypertension monographs, the 2025 AHA/ACC blood pressure guideline and the ATS race-neutral statement. Synthetic findings introduced: chronic rhinosinusitis without nasal polyps on nasal endoscopy. One protocol deviation is recorded instead of an invented result: the in-person review within a week of the exacerbation that the CMID schedule and GINA call for was not booked (the nurse telephoned on days 2 and 7); no harm, since she recovered fully and was well controlled six weeks later; corrective action: the action plan and the exacerbation order set now book a visit within seven days.
- Consultation. The pulmonology referral and the consultation by Samuel Oyelowo-Brandt, MD (a fictional consultant), on the diagnosis day, are S. The consultant answers the six referral questions in line with what the record shows afterwards: asthma, not COPD, with heart failure excluded and hypertensive heart disease found; race-neutral interpretation; budesonide-formoterol maintenance and reliever with albuterol stopped; type 2 phenotype without current eligibility for biologics; upper airway, reflux and blood pressure treatment; and an action plan, technique checks and vaccinations.
- Real people. Her husband appears only in the claims; her son and grandchildren are not named. No relative, colleague or friend is given a decision, a statement or a health fact in the modern episode, and the health care surrogate is unnamed. The president and the first lady of her Washington years are not named in the record, and no other figure with a record in the dataset is named.
Protocol deviations
Checks the monitoring protocol called for that the schedule did not perform. Each is recorded with its outcome and corrective action, never filled with an invented result.
| Visit | Measure | Interval | What happened |
|---|
2026-07-27 Progress note 05 (C-CDA) | Review after an exacerbation | Within one week of any exacerbation (CMID; GINA within one to seven days) | Missed: after the exacerbation at the sick visit the nurse telephoned on days 2 and 7, but no in-person review was booked within a week. No harm resulted: she recovered fully and is well controlled today. Corrective action: the action plan and the clinic's exacerbation order set now book a visit within seven days automatically |
Orders and referrals without results in the record
| Visit | Type | Item | Status | Detail |
|---|
2026-09-21 Progress note 06 (C-CDA) | Prevention | Bone density (DXA) | Ordered | Recommended for women 65 and older; none on record; recent oral corticosteroid |
2026-09-21 Progress note 06 (C-CDA) | Prevention | Breast cancer screening | Ordered | Biennial mammography to age 74; last mammogram two years ago |
Evidence to check
Retrospective claims (R)
| Claim | Statement | Certainty |
|---|
| CLM-0011 | Retrospective interpretation: a fatal heart attack at 79 is most consistent with coronary heart disease, but no source found describes heart symptoms, a cardiac diagnosis or blood pressure readings during her life. | possible |
Sensitive claims
None.
Diagnoses not confirmed
None.
Notes to read
Every note in the record, with its type. All clinical content is synthetic.
Abnormal results
| Date | Result | Value | Flag |
|---|
| 2026-03-09 | Glucose | 102 mg/dL (high) | High |
| 2026-03-09 | Hemoglobin A1c | 5.9% (high) | High |
| 2026-03-09 | Total cholesterol | 228 mg/dL (high) | High |
| 2026-03-09 | LDL cholesterol | 144 mg/dL (high) | High |
| 2026-06-15 | Peak expiratory flow | 205 L/min (low) | Low |
| 2026-03-23 | FEV1 before bronchodilator | 1.3 L (low) | Low |
| 2026-03-23 | FEV1 percent predicted before bronchodilator | 64% (low) | Low |
| 2026-03-23 | FEV1/FVC before bronchodilator | 0.64 (low) | Low |
| 2026-03-23 | FeNO | 46 [ppb] (high) | High |
| 2026-03-23 | Total IgE | 210 [IU]/mL (high) | High |